Sp1 is overexpressed in a variety of cancers including liver, breast, colon, pancreas, bladder and prostate cancer, and plays an important role in cell proliferation by activating the expression of several cell cycle regulatory proteins [43]. Here, RCC1 is linked to prostate cancer.